Warning letter
Private Label Skin Care, Inc.: warning letter of Dec 18, 2025
FDA warning letter 715880 · Center for Drug Evaluation and Research (CDER)
Key facts
| Reference number | 715880 |
|---|---|
| Company | Private Label Skin Care, Inc. |
| Subject | CGMP/OTC/Adulterated/Misbranded |
| Issue date | Dec 18, 2025 |
| Posted date | Dec 30, 2025 |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Product type | Drugs |
| CFR sections cited | 211.22(a), 207.53, 207.41(a), 207 |
| Inspection city | Canoga Park |
| Inspection ZIP | 91304 |
| Inspection start date | Jun 16, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: